ADALIMUMAB
Presentation: 50mg/mL of adalimumab containing two syringes. Each syringe contains 0.8mL, which represents 40mg of adalimumab solution for injection per syringe.
Used for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, hidradenitis suppurativa, and uveitis.
ETANERCEPT
Presentation: Cartridge with 4 syringes filled with 1 mL of solution for injection, containing 50 mg of etanercept each.
Used for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
GOLIMUMAB
Presentation: Injectable solution of 50 mg/0.5 mL of golimumab, in a pack with 1 applicator pen.
Used for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.
INFLIXIMAB
Presentation: 1 vial with 100 mg of infliximab.
Used for the treatment of Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.
RITUXIMAB
Presentation: 100 and 500 mg injectables (via vials of 10mL and 50mL).
Used for the treatment of rheumatoid arthritis.
